Prior to joining Easton in 2009, Kresimir was a Howard Hughes Medical Institute Predoctoral Fellow at Yale University where he led multi-disciplinary research projects linked to the areas of neurology, cancer and diabetes. Kresimir also led the development of computational technologies for application in biomedical imaging. He first-authored papers published in leading academic journals, including Nature, Nature Neuroscience and PNAS. Kresimir previously worked at Fletcher Spaght Ventures, a venture capital fund, The Channel Group, a life sciences advisory firm, and Lesanne Life Sciences, a stroke diagnostic startup company. His expertise includes health information technology, biotech, diagnostics, and devices. Kresimir has helped build and continues to lead Easton's Healthcare IT practice. Kresimir is a board director and chief business officer in Medikly, a board director in Wildflower Health and a board observer in KitCheck, Precise Light Surgical, SolX, and WellTrackOne. He is also a class 15' Kauffman Fellow. Kresimir completed both his PhD in neuroscience and MBA at Yale University. He earned his MD at Zagreb University, Croatia.